Additional file 1: Table S1. of A quantitative analysis of therapeutic cancer vaccines in phase 2 or phase 3 trial

Vaccine categories in trial completed prior to 2013, or with planned completion post 2013. Table S2. Endpoints included in Phase 2 & Phase 3 trial protocols. Table S3. Platform, adjuvant and antigen-loading variants within vaccine categories. (DOCX 39 kb